PIPELINE

 

CLINICAL TRIALS

Phase I/IIa Trial Evaluating Safety of LOAd703, an Armed Oncolytic Adenovirus for Pancreatic Cancer (NCT02705196)

Photo: David Magnusson

 

Copyright ©2014, All other marks are the property of their respective owners.